Yayınlar & Eserler

Yayın Ağı
Makaleler 8
Tümü (8)
SCI-E, SSCI, AHCI (7)
SCI-E, SSCI, AHCI, ESCI (8)
ESCI (1)
Scopus (8)

1. Potent soluble epoxide hydrolase inhibitors based on thiazole-5-carboxamide structure with imidazolidinone moiety as a secondary pharmacophore

LENGERLİ D., KOÇ B., Jordan P. M., ÇALIŞKAN K., ÇALIŞKAN B., Werz O., et al.
Bioorganic Chemistry , cilt.163, 2025 (SCI-Expanded) identifier identifier

2. Phenyl-benzyl-ureas with pyridazinone motif: Potent soluble epoxide hydrolase inhibitors with enhanced pharmacokinetics and efficacy in a paclitaxel-induced neuropathic pain model

LENGERLİ D., Bakht A., ÇALIŞKAN K., Dahlke P., BAL N. B., Jordan P. M., et al.
European Journal of Medicinal Chemistry , cilt.290, 2025 (SCI-Expanded) identifier identifier identifier

3. Isoxazole-pyrimidine derivatives as TACC3 inhibitors: A novel modality to targeted cancer therapy

LENGERLİ D., Çalışkan Ö. A., ÇALIŞKAN K., Saatci Ö., Lim C., Vempati S., et al.
Bioorganic Chemistry , cilt.156, 2025 (SCI-Expanded) identifier identifier

4. Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification

Saatci O., Akbulut O., Cetin M., Sikirzhytski V., ÜNER M., LENGERLİ D., et al.
Cell Death and Differentiation , cilt.30, sa.5, ss.1305-1319, 2023 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

5. The 1,2,3-triazole 'all-in-one' ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool.

Lengerli D., Ibis K., Nural Y., Banoglu E.
Expert opinion on drug discovery , cilt.17, sa.11, ss.1209-1236, 2022 (SCI-Expanded) identifier identifier identifier

6. Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with in Vitro Growth Inhibitory and in Vivo Antitumor Activity

Turanll S., NALBAT E., LENGERLİ D., İBİŞ K., Güntekin Ergün S., Akhan Güzelcan E., et al.
ACS Omega , cilt.7, sa.41, ss.36206-36226, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

7. Crystal structure and Hirshfeld surface analysis 4-(4-chlorophenyl)-5-methyl-3-{4-[(2-methylphenyl)methoxy]pnenyl}-1,2-oxazole

Aydin A., AKKURT M., TURANLİ S., LENGERLİ D., BANOĞLU E., Ozcelik N. D.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS , cilt.77, ss.346-356, 2021 (ESCI) Creative Commons License identifier identifier identifier

8. A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate

Akbulut O., Lengerli D., Saatci O., Duman E., ŞEKER U. Ö. Ş., Isik A., et al.
MOLECULAR CANCER THERAPEUTICS , cilt.19, sa.6, ss.1243-1254, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 16

1. SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL THIAZOLIDINE-2,4-DIONE DERIVATIVES AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS

Kara S., Lengerli D., Jordan P. M., Werz O., Banoğlu E.
X EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry (EFMC-ASMC 2025), Porto, Portekiz, 31 Ağustos - 04 Eylül 2025, ss.302, (Özet Bildiri)

2. EVALUATION OF NOVEL THIAZOLE-5-CARBOXAMIDE-IMIDAZOLIDINONE DERIVATIVES AS POTENT HUMAN SOLUBLE EPOXIDE HYDROLASE INHIBITORS

LENGERLİ D., KOÇ B., JORDAN P. M., ÇALIŞKAN K., ÇALIŞKAN B., WERZ O., et al.
59th International Conference on Medicinal Chemistry (RICT 2025), Orleans, Fransa, 02 Temmuz 2025, (Özet Bildiri)

3. Vicinal Diaryl-Substituted Compounds: Promising Therapeutics for Breast Cancer

NALBAT E., GÜNTEKİN ERGÜN S., TURANLI S., LENGERLİ D., ÇALIŞKAN B., BANOĞLU E., et al.
2024 Annual Congress of the European Association for Cancer Research (EACR 2024), Rotterdam, Hollanda, 10 - 13 Haziran 2024, (Özet Bildiri)

4. Identifying the interactome of TACC3, a major driver in aggressive cancer cells with centrosome amplification

Saatci O., Akbulut O., Cetin M., Sikirzhytski V., ÜNER M., LENGERLİ D., et al.
San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 5 - 09 Aralık 2023, (Özet Bildiri) identifier

5. PYRIDAZINYL-PHENYL BENZYL UREA DERIVATIVES AS HUMAN SOLUBLE EPOXIDE HYDROLASE (sEH) INHIBITORS

Bakht A., LENGERLİ D., Jordan P. M., İBİŞ K., ÇALIŞKAN B., Werz O., et al.
Medicinal Chemistry Frontiers 2024, Utrecht, Hollanda, 08 Nisan 2024, (Özet Bildiri)

6. Targeting hepatocellular carcinoma: evaluation of vicinal diaryl isoxazole and pyrazole derivatives with implications for oxidative stress and senescence-mediated anti-tumor mechanisms

Nalbat E., Akhan Güzelcan E., Turanlı S., Lengerli D., Çalışkan B., Banoğlu E., et al.
EASL Liver Cancer Summit 2024, Rotterdam, Hollanda, 22 - 24 Şubat 2024, ss.76, (Özet Bildiri)

7. Exploring novel vicinal diaryl-substituted isoxazole and pyrazole derivatives as cytotoxic compounds for targeting breast cancer: Mechanisms and therapeutic potential

NALBAT E., GÜNTEKİN ERGÜN S., TURANLI S., LENGERLİ D., ÇALIŞKAN B., BANOĞLU E., et al.
XVIII. Tıbbi Biyoloji ve Genetik Kongresi, Ankara, Türkiye, 26 - 29 Ekim 2023, (Özet Bildiri)

8. A NOVEL SERIES OF ANTIPYRINE-UREA ANALOGUES: DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION AS INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE

LENGERLİ D.
International Multidisciplinary Symposium on Drug Research and Development (DRD) 2023, 4 - 06 Mayıs 2023, (Özet Bildiri)

9. Design, Synthesis and Biological Evaluation Of Novel Imidazolidinone-Thiazole Amide Hybrids As Inhibitors Of Human Soluble Epoxide Hydrolase

İBİŞ K., LENGERLİ D., JORDAN P., ÇALIŞKAN B., WERZ O., BANOĞLU E.
9th EFMC Young Medicinal Chemists' Symposium, Nice, Fransa, 08 Eylül 2022, (Özet Bildiri)

10. STUDIES ON THE SYNTHESIS AND ANTICANCER POTENTIAL OF NOVEL 2,4-DIAMINOPYRIMIDINE DERIVATIVES

Lengerli D., Akbulut Çalışkan Ö., Çalışkan B., Şahin Ö., Banoğlu E.
The 9th Young Medicinal Chemist Symposium (EFMC-YMCS 2022), Nice, Fransa, 8 - 09 Eylül 2022, (Özet Bildiri)

11. TACC3 İnhı̇bı̇törü Yenı̇ 2,4-Dı̇amı̇nopı̇rı̇mı̇dı̇n Türevlerı̇nı̇n Sentezı̇, Antı̇-Kanser Etkı̇ Potansı̇yellerı̇ ve İlaç Benzerı̇ Özellı̇klerı̇nı̇n Değerlendı̇rı̇lmesı̇ Üzerı̇ne Çalışmalar

LENGERLİ D., AKBULUT ÇALIŞKAN Ö., ÇALIŞKAN B., ŞAHİN Ö., BANOĞLU E.
VI. Ulusal Farmasötik Kimya Kongresi, İstanbul, Türkiye, 26 Ağustos 2022, (Özet Bildiri) Sürdürülebilir Kalkınma

12. Synthesis of 3,4-Diaryl-5-methylisoxazoles with Potent Antiproliferative Activity Against a Panel of Human Liver and Breast Cancer Cell Lines

LENGERLİ D., TURANLİ S., ÇALIŞKAN B., AKHAN GÜZELCAN E., NALBAT E., ATALAY R., et al.
EFMC-ISMC EFMC-YMCS Virtual Poster Session, 09 Eylül 2020, (Özet Bildiri) Sürdürülebilir Kalkınma

13. Synthesis of New Vicinal Diaryl Five-Membered Heterocyclic Compounds with Potential Anticancer Activity

TURANLİ S., LENGERLİ D., ÇALIŞKAN B., AKHAN GÜZELCAN E., NALBAT E., ATALAY R., et al.
8th International Drug Chemistry Conference, 27 Şubat - 01 Mart 2020, (Özet Bildiri)

14. A SMALL MOLECULE INHIBITOR OF TRANSFORMING ACIDICCOILED-COIL PROTEIN 3 (TACC3): A NOVEL THERAPEUTICSTRATEGY FOR THE TREATMENT OF BREAST CANCER

LENGERLİ D., Akbulut O., ÇALIŞKAN B., ŞAHİN Ö., BANOĞLU E.
11th Joint Meeting on Medicinal Chemistry 2019, PRAG, Çek Cumhuriyeti, 27 - 30 Haziran 2019, (Özet Bildiri) Sürdürülebilir Kalkınma

15. Abstract 3871: A novel TACC3 inhibitor as an anti-cancer agent in breast cancer

Akbulut O., LENGERLİ D., Saatci O., Duman E., Seker U., ÇALIŞKAN B., et al.
Experimental and Molecular Therapeutics, 29 Mart - 03 Nisan 2019 Sürdürülebilir Kalkınma

16. A Novel TACC3 inhibitor as an anti-cancer agent in breast cancer

AKBULUT ÇALIŞKAN Ö., LENGERLİ D., ÇALIŞKAN B., BANOĞLU E., ŞAHİN Ö.
30th EORTC-NCI-AACR Symposium, Dublin, İrlanda, 13 - 16 Kasım 2018, (Özet Bildiri)
Metrikler

Yayın

24

Yayın (WoS)

9

Yayın (Scopus)

8

Atıf (WoS)

128

H-İndeks (WoS)

4

Atıf (Scopus)

132

H-İndeks (Scopus)

4

Atıf (Scholar)

120

H-İndeks (Scholar)

4

Proje

6

Fikri Mülkiyet

28

Açık Erişim

2
BM Sürdürülebilir Kalkınma Amaçları